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■ Abstract Background Inhibition of proteolytic MMP activity could be a
therapeutic approach to prevent ventricular dilatation by diminishing colla-
gen matrix turnover and interstitial fibrosis.We investigated the time-course
of MMP/TIMP activity during transition from hypertrophy to ventricular
dilatation in transgenic mice with myocyte overexpression of the human β1-
adrenergic receptor (β1TG). These β1TG mice were studied at 3 (normal
function), 5 (hypertrophy) and 12 (ventricular dilatation) months of age
compared to age-matched controls (WT).Methods Picro Sirius red staining
and real-time PCR were performed for total collagen and for collagen type I
and III quantification,respectively.MMP-activity assays (zymography),im-
munoblotting and real-time PCR experiments were done for gelatinase-
(MMP-2, -9), collagenase- (MMP-1, -13), membrane-type MMP- (MT1-
MMP; MMP-14) and TIMP expression measurements.To investigate β1-in-
tegrin activity,integrin-linked kinase (ILK) expression was measured by im-
munoblotting. Results  Compared to WT with normal cardiac function,
interstitial collagen type I and III mRNA and protein expression increased
3.6-fold in β1TG at 5 months of age with moderate fibrosis and cardiomy-
ocyte hypertrophy and 17-fold in β1TG at 12 months of age with severe fi-
brosis and ventricular dilatation. Protein expression of the collagenases
MMP-1 and -13 as well as the gelatinase proMMP-2 increased in the β1TG
group with cardiac hypertrophy.Maximal activity of the gelatinase MMP-2
(3.5-fold vs.WT) was measured in β1TG at 12 months of age with severe fi-
brosis and ventricular dilatation, accompanied by coexpression of MT1-
MMP (3.8-fold vs.WT) colocalized to the cell membranes.Conclusion These
data provide evidence that sympathetic overactivation can trigger intersti-
tial matrix remodeling and fibrosis by induction of MMP/TIMP activity.In
particular gelatinolytic MMP-2 activity accompanies ventricular dilatation
and the development of heart failure.
■ Key words heart failure – myocardial fibrosis – cardiac remodeling –
β1-adrenergic receptors – matrix metalloproteinases
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Introduction
Interstitial fibrosis, altered collagen cross-link forma-
tion and impairment of diastolic and systolic ventricu-
lar function are markers of advanced heart failure and
are potentially influenced by neuroendocrine activation
and β-adrenergic signal transduction changes,which go
in parallel with a poor prognosis [5, 23, 30]. Enzymes
known for degradation of collagen fibrils and extracel-
lular matrix proteins are the MMP (matrix metallopro-
teinases) family.The isoforms are characterized by sub-
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strate specificity.Dysbalance of MMP activity and their
endogenous MMP inhibitors (TIMPs) plays a pivotal
role in myocardial interstitial matrix remodeling lead-
ing to enhanced collagen turnover and a reduction in
fibrillar collagen cross-link formation and influences
myocardial systolic and diastolic function [17, 31] Sys-
tolic heart failure in humans [13, 19] and hypertensive
cardiac hypertrophy [16,21,27] or remodeling after my-
ocardial infarction [21] in animal models are associated
with enhanced MMP activity and reduced TIMP expres-
sion in left ventricular myocardium. It is important to
understand MMP-isoform regulation by different stim-
uli, such as chronic sympathetic overactivation. MMPs
are synthesized in cardiomyocytes [8] as well as fibro-
blasts [33].Most of the MMP isoforms are stored as zy-
mogens (proMMPs) in the interstitium before being ac-
tivated [6]. The collagenase group of MMPs includes
MMP-1 (interstitial collagenase) and MMP-13 (collage-
nase-3) cleaving triple helical cross-linked fibrillar col-
lagens, such as types I, II and III. Gelatinases MMP-2
(gelatinase A) and MMP-9 (gelatinase B) are involved in
degrading gelatins (collagen fragments) and cleaving
basement membrane matrix proteins, such as collagen
types IV, V, VII. In addition these gelatinases cleave fi-
bronectin at the amino acid sequence Arg-Gly-Asp
(RGD sequence). Fibronectin is responsible for cross-
linking of extracellular collagens to cell membrane inte-
grins. The membrane-type MMPs (MT-MMPs) have
been colocalized to the cell membrane in proximity to
the ECM-binding integrins. α2β1 integrin is the major
collagen type I receptor. Integrin-linked kinase (ILK)
regulates integrin-mediated cellular processes like fi-
bronectin matrix assembly, cell survival and prolifera-
tion [32].Inhibition of MMP activity could be an inter-
esting therapeutic approach by preventing ventricular
dilatation in order to diminish collagen matrix turnover
and fibrosis.The induction of MMP/TIMP species dur-
ing transition to and from hypertrophy to ventricular
dilatation is not known in detail. We investigated the
time-course of MMP/TIMP activity related to the car-
diac phenotype in transgenic mice with 15-fold α-MHC-
targeted cardiomyocyte overexpression of the human
β1-adrenergic receptor (β1TG) developing heart failure
within one year. These transgenic mice were generated
from FVB/N mice as reported earlier [11].Investigations
were performed at 3 (normal function),5 (hypertrophy)
and 12 (ventricular dilatation) months of age compared
to age-matched controls (WT).
Methods
■ Picro Sirius red staining
Left ventricular tissue specimens obtained from β1TG
mice and wild-type (WT) control animals were fixed in
4% formalin/PBS solution and processed for paraffin
embedding. After hydration of the deparaffinized left
ventricular circumferential sections (6μm) samples
were incubated in 0.1% Sirius red in a saturated solution
of picric acid for 60 min. Unbound Sirius red was re-
moved with 0.01 N HCl. Samples were examined and
photographed at a magnification of 10× with a Nikon
E600 microscope (Nikon, Düsseldorf, Germany). Five
fields located in the middle third of the myocardium
(covering the majority of the myocardium) were evalu-
ated.Perivascular fibrosis was estimated from cross sec-
tions of coronary arteries. Picro sirius red stain high-
lights collagen type I by yellow-red birefringence and
collagen type III by green birefringence (polarized
light). Analysis and quantification of total interstitial
fibrillar collagen content were performed with digital
image software Lucia G (Nikon, Düsseldorf, Germany).
Data are presented as fractional area of collagen content
in % of myocardial tissue.A single investigator blinded
to the experimental groups performed the analysis.
■ Tissue sampling
Similar amounts (35mg) of left ventricular myocardium
from β1TG at 3, 5 and 12 months of age as well as age-
matched WT control animals were homogenized and
lysed in extraction buffer containing 10mmol/l ca-
codylic acid pH 5.0, 0.15 mol/l NaCl, 1μmol/l ZnCl2,
20mmol/l CaCl2,1.5mmol/l NaN3,and 0.01% (v/v) Tri-
ton X-100.After incubation over night at 4 °C and cen-
trifugation at 1200g the supernatants were collected and
pH was raised to 7.5 for zymography experiments.Pro-
tein concentrations were measured using a detergent
compatible kit (DC protein assay,Bio-Rad,Munich,Ger-
many). For zymography- and immunoblotting-elec-
trophoresis, minigels of 0.8mm thickness were used
(Bio-Rad,Munich,Germany).
■ Immunoblotting
Cardiac tissue samples (25μg protein/lane) were ho-
mogenized, denatured (95 °C) and separated on 12%
(TIMP-1,TIMP-2) and 10% (MMPs,ILK) SDS-polyacry-
lamide gels, transferred to nitrocellulose membranes
(ProtranR, Schleicher & Schuell GmbH, Dassel, Ger-
many) by semi-dry electrophoretic blotting and sub-
jected to Western blot analysis. Equal loading of total
cardiac protein was controlled by Poinceau red staining
and through calsequestrin immunoreactivity (PA1–913,
Dianova, Hamburg, Germany). Membranes were
blocked with Western Blocking Reagent (Roche,Mann-
heim, Germany) and incubated at 37 °C with mono-
clonal mouse MMP-1 (IM 35 L,Calbiochem Bad Soden,
Germany), -9 (IM 10 L, Calbiochem), -13 (IM 81, Cal-
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biochem), MT1-MMP (IM 57 L, Calbiochem), TIMP-1
(IM 32 L, Calbiochem), TIMP-2 (IM 11 L, Calbiochem)
and rabbit anti-ILK (06–592, Biomol, Hamburg, Ger-
many) antibodies, all diluted at 1:1000. The interstitial
collagenase antibody (MMP-1) recognizes an epitope
from amino acid 349–357 of the human interstitial col-
lagenase. The coding sequence of the murine counter-
part for the interstitial collagenase is very similar to the
human sequence [3].This antibody detects latent MMP-
1 at 57/52 kD and the active form at 46/42 kD.Goat anti-
mouse and goat anti-rabbit peroxidase labeled sec-
ondary antibodies were diluted 1:10.000 and incubated
90 min at room temperature (RT).Proteins were visual-
ized by enhanced chemiluminescence (ECL) according
to the manufacturer’s guidelines (Amersham Pharmacia
Biotech, Freiburg, Germany). MMP control-1 (Sigma,
Deisenhofen, Germany) was used as a qualitative posi-
tive control for MMP-1, -9, TIMP-1 and -2. Autoradi-
ographs were quantified by imaging densitometry and
analyzed by the “ImageQuant-TM” Software (Image
Quant, Molecular Dynamics, Krefeld, Germany). Data
are presented as optical density (OD) in percent of a
control sample.
■ Zymography
Zymography detects degradative properties of gelati-
nases by integrating gelatin as a substrate into the gel.
Gelatin type B from bovine skin (Sigma, Deisenhofen,
Germany) was added to standard Laemmli acrylamide
polymerization mixture at final concentrations of
1mg/ml. Tissue extract (50μg) was mixed with sample
buffer (10% w/v SDS, 4% w/v sucrose, 0.1% w/v bro-
mophenol blue) and loaded into slots ofthe 0.8mm 10%
acrylamide stacking gel. Gels were run at 20 mA and
soaked in 2.5% w/v Triton X-100 with gentle shaking for
60 min at RT.Gels were incubated over night at 37 °C in
substrate buffer (50mmol/l Tris-Cl,pH 8.0 and 5mmol/l
CaCl2),stained in 0.05% Coomassie Brilliant Blue G-250
(Bio-Rad, Munich, Germany) diluted in ethanol,
destained in acetic acid/ethanol and dried.Supernatant
of HT 1080,a human fibrosarcoma cell line,was used as
positive control for MMP-2 and –9.Quantification of the
size-fractionated banding pattern was performed by
densitometry. Each sample lane was scanned and pre-
sented as optical density (OD) in percent of control
sample.
■ Reverse transcription
Total RNA from deep frozen left ventricular tissue of
β1TG and WT controls at 3,5 and 12 months of age was
prepared according to the method of Chomczynski and
Sacci [7] with PeqGOLD RNAPure® (Peqlab Biotechnol-
ogy, Erlangen, Germany). RNA was quantified spectro-
metrically and ethidium bromide-stained agarose gels
were used to check its integrity. Complementary DNA
(cDNA) was transcribed from the RNA template using
Sensiscript Reverse Trancriptase (Qiagen, Hilden, Ger-
many) and random hexamer primers (Roche, Mann-
heim, Germany) according to the manufacturer’s pro-
tocol.
■ Real-time quantitative polymerase chain reaction
(RT-PCR)
Real-time PCR (Applied Biosystems,Germany) was per-
formed in 23μl PCR Master Mix buffer volume (Sybr
Green, dNTPs, AmpliTaqGold DNA polymerase), 2μl
(10ng) template DNA and 200 nM ofsense and antisense
primer designed for conserved regions of the genes
(Table1). PCR was performed according to a two-step
PCR protocol (5 min at 95 °C,40 cycles for 15 s at 95 °C,
1 min at 59 °C).The ABI PRISM Sequence Detection Sys-
tem 7700 (Applied Biosystems) was used to detect the
fluorescent (Sybr Green) signal which reflects the expo-
Table1 Primer sequences used for real-time quantitative polymerase chain
reaction
5’- 3’ sequence Accession
number
Pro-collagen type I (α2) X58251
primer sense GTAAACACCCCAGCGAAGAACTC
primer antisense TCAAACTGGCTGCCACCAT
Pro-collagen type III (α1) X52046
primer sense ACCCAGAGATCCCATTTGGAG
primer antisense AGGAAGCACAGGAGCAGGTG
Matrix metalloproteinase-2 NM008610
primer sense CGCTCAGATCCGTGGTGAG
primer antisense GGCTTGTCACGTGGTGTCAC
Matrix metalloproteinase-13 X66473
primer sense AGAGGGTCTTCCCCGTGTTCT
primer antisense GGCTCTGAATGGTTATGACATTCTG
MT1-MMP U54984
primer sense AACTTTGACACCGTGGCCA
primer antisense CAATGGGCATTGGGTATCC
TIMP-1 NM011593
primer sense CACTCACTGTTTGTGGACGGA
primer antisense CAAGCAAAGTGACGGCTCTG
TIMP-2 NM011594
primer sense GCAAGATGCACATTACCCTCTGT
primer antisense CAGGCTCTTCTTCTGGGTGATG
GAPDH M32599
primer sense CCTGGACCACCCAGCCCAGCA
primer antisense TGTTATGGGGTCTGGGATGGA
MT1-MMPmembrane type 1- matrix metalloproteinase, TIMP-1tissue inhibitor of
matrix metalloproteinase-1, GAPDHglyceraldehydes-3-phosphate dehydrogenase
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nential accumulation of the PCR product.Threshold cy-
cle (Ct) values were determined using the Sequence De-
tector 1.7 software.Dissociation curves were performed
to control the specificity of the amplification product.
Values are presented as the ratio of target mRNA to
GAPDH of the same sample.An external GAPDH stan-
dard curve has been used to calculate Ct values in pg.
■ Statistical analysis
Data are expressed as mean±SEM. Statistical signifi-
cance was estimated with one way analysis of variance
and Bonferroni t-test. A probability value <0.05 was
considered significant.
Results
■ Increased interstitial collagen content
Fig.1A shows increased interstitial collagen content in
β1TG compared to WT mice. Interstitial total fibrillar
collagens in β1TG increased from 0.9% (3 months) to
3.6% (5 months) and finally to 17% fractional area of
left ventricular myocardial tissue at 12 months com-
pared to age-matched WT animals with 1.5% interstitial
collagen fibers. The ratio of myocardial collagen type I
to type III was unchanged (polarized light).Perivascular
fibrosis was not significantly altered in β1TG compared
to WT mice. The increase of collagen protein content
was accompanied by a 4.5-fold increase of pro-collagen
type I (α2) and type III (α1) mRNA expression mea-
sured by quantitative real-time PCR at 12 months of age
(Fig.1B).
■ Collagenases increased in cardiac hypertrophy
Total protein expression of the collagenase MMP-13 (60
kD) significantly increased up to 3.6-fold in the β1TG
group at 5 months of age in mice with myocardial hy-
pertrophy and moderate interstitial fibrosis compared
to mice without myocardial alterations. MMP-13 de-
creased in β1TG at 12 months of age with ventricular di-
latation and severe fibrosis (MMP-13 [OD], WT: 3m
0.9±0.04, 5m 1.9±0.2, 12m 1.2±0.2, TG: 3m 1.0±0.1,
5m 3.7±0.3, 1m 1.8±0.6, n=6). MMP-13 antibody de-
tects total protein expression (Fig.2A).To confirm these
results and for further differentiation in latent and ac-
tive isoforms we used an antibody for interstitial colla-
genase MMP-1. The non-glycosylated latent proMMP-1
(57/52 kD) isoform also increased (4.6-fold) in β1TG
mice at 5 months of age and decreased with 12 months
(proMMP-1 [OD],WT: 3m 0.5±0.09, 5m 2.5±0.1, 12m
1.3±0.3, TG: 3m 0.9±0.1, 5m 4.0±0.4, 1m 1.5±0.4,
n=6). Active MMP-1 (47 kD) continuously increased
with disease progression from hypertrophy (2.3-fold) to
ventricular dilatation (4.5-fold) in β1TG mice (active
MMP-1 [OD], WT: 3m 0.8±0.06, 5m 0.9±0.09, 12m
0.8±0.2, TG: 3m 0.9±0.1, 5m 2.0±0.5, 1m 4.0±1.0,
n=6; Fig.2B). MMP-13 mRNA expression determined
by real-time PCR was not different between all groups.
■ Tissue inhibitor of matrix metalloproteinase-1 
(TIMP-1) increased with aging
Protein expression of TIMP-1 (28 kD) increased in both,
with aging in the WT groups and with disease progres-
sion in the β1TG groups.However,protein enhancement
was more pronounced in the β1TG mice groups (TIMP-
1 [OD]: WT: 3m 4.4±0.6, 5m 12.5±1.2, 12m 38.6±5.7,
TG: 3m 6.6±0.9,5m 22.8±4.3,12m 44.9±6.6,n=5).
■ Gelatinolytic activity of MMP-2 was associated 
with ventricular dilatation
Zymography detects the latent (72/69 kD) and active
(66/59 kD) form of gelatinase-A, MMP-2 (Fig.3A).
ProMMP-2 (72 kD) protein expression continuously in-
creased in the β1TG group from 3 to 12 months of age
compared to the age-matched WT control group.Active
MMP-2 (66 kD) degrades gelatins and fibronectin, re-
sponsible for collagen crosslinking.MMP-2 activity has
been detected in some of the β1TG at 5 months of age
but significantly increased up to 3.5-fold (vs.WT) in the
β1TG group at 12 months of age characterized by severe
interstitial fibrosis and ventricular dilatation (proMMP-
2 [OD] WT:3m 0.6±0.02,5m 0.75±0.08,12m 0.8±0.02,
TG: 3m 0.8±0.07, 5m 1.2±0.07.12m 1.4±0.1; MMP-2
(active): WT 12m 0.04±0.01, TG 12m 0.1±0.03, n=5).
MMP-2 mRNA expression measured by real-time PCR
was upregulated (4.4-fold) in β1TG mice at 12 months of
age compared to β1TG and WT at 3- and 5 months of age
(Fig.3B).
■ TIMP-2 increased with progressive cardiac
dysfunction
TIMP-2 (24 kD) protein level and mRNA expression
continuously increased in the β1TG group from 3
months to 12 months of age with disease progression
compared to age matched WT mice (TIMP-2 [OD] WT:
3m 2.0±0.46, 5m 6.97±0.98, 12m 6.0±1.3, TG: 3m
3.0±0.8,5m 8.0±1.37.12m 12.2±1.2,n=5; Fig.4).
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Fig.1 AMyocardial interstitial and perivascular col-
lagen. Picro sirius red (total collagen) stained circum-
ferential midmyocardial sections of the left ventricle
(magnification 10×) of β1-adrenergic receptor trans-
genic mice (β1TG) at 3 months (without fibrosis), 5
months (myocyte hypertrophy and moderate fibro-
sis) and 12 months of age (ventricular dilatation and
severe interstitial fibrosis) compared to age-matched
wild-type (WT) controls. Right: Perivascular fibrosis
did not differ in β1TG compared to WT at any age.
Analysis and quantification was performed with dig-
ital image software Lucia G (Nikon, Düsseldorf, Ger-
many). Data are presented as fractional area of colla-
gen content in % of myocardial tissue of n=5 per
group. B Quantitative real-time PCR of pro-collagen
type I (α2) mRNA. Threshold cycle (Ct) values are pre-
sented as a ratio of pro-collagen type I (α2) mRNA to
GAPDH mRNA (left). Representative amplification
plot (ABI Prism 7700 detection system) Rn normal-
ized reporter signal (right)
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■ MT1-MMP (MMP-14) expression increased 
with ventricular dilatation
MT1-MMP (58 kD) protein expression measured in left
ventricular homogenates of β1TG mice at 5 months of
age increased significantly (1.6-fold) compared to β1TG
mice at 3 months of age and increased further up to 2.4-
fold measured in the β1TG group at 12 months of age
(MMP-14 [OD] WT: 3m 0.3±0.03, 5m 0.5±0.1, 12m
0.6±0.2,TG:3m 0.3±0.03,5m 0.5±0.07,12m 1.2±0.13,
n=5;Fig.5A).In parallel MT1-MMP mRNA expression,
measured by quantitative real-time PCR,increased sig-
nificantly with disease progression in the β1TG group
up to 2.8-fold at 12 months of age (Fig.5B).
■ Integrin-linked kinase (ILK) decreased 
with ventricular dilatation
Protein expression of this serine/threonine kinase inter-
acting with the β1 integrin cytoplasmic domain was sig-
nificantly downregulated by 69% in β1TG at 12 months
of age with severe interstitial fibrosis and left ventricu-
lar dilatation compared to age-matched WT.ILK was not
regulated in WT and younger β1TG mice before onset of
ventricular dilatation and severe fibrosis (ILK [OD] WT:
3m 192.4±13.8,5m 180.2±18.6,12m 183.3±19,TG: 3m
169.7±10,5m 143.9±11,12m 66.6±6.6,n=5; Fig.6).
Discussion
In this study interstitial matrix remodeling was ex-
plored in β1-adrenoceptor transgenic mice [11]. In
ß1TG,an increase in cardiac function is followed by ven-
tricular hypertrophy at 5 months of age [11].Transition
from a compensated LV hypertrophic state to LV dilata-
tion and dysfunction occurred in β1TG mice at the age
of 5 to 9 months and is most pronounced in β1TG mice
at the age of 12 months [32]. As shown by expression
analyses (histology, real-time PCR, immunoblotting)
and proteinase activity assays (zymography), β1-
adrenoceptor transgenic mice (ß1TG) developed pro-
gressive interstitial fibrosis that preceded systolic func-
tional decline [11, 12] as studied earlier. Fibrosis was
most pronounced at the age of 12 months.
A B
Fig.2 A Immunoblot analysis of MMP-13 collagenase protein expression and
densitometric quantification. Corresponding blot of the housekeeping protein
calsequestrin is shown below. B Densitometric quantification of the collagenase
pro-MMP-1 (latent) and active MMP-1 protein expression measured by im-
munoblotting
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ocardial contractility associated with impaired Ca2+-
handling in β1TG mice [11, 12]. Badenhorst etal. re-
cently suggested that chronic sympathetic activation
significantly contributes to progression from compen-
sated left ventricular hypertrophy to cardiac dysfunc-
tion through deleterious cardiac matrix remodeling [1,
2]. Our data suggest that β-adrenergic overactivity by
β1-adrenergic receptor overexpression is accompanied
by interstitial matrix remodeling and turnover by in-
duction of MMP/TIMP activity in parallel to cardiac
phenotype changes. Increased gene expression of
proMMP-2 and MT1-MMP (MMP-14) contributes to en-
hanced protein expression and activation of 72 KDa
gelatinase (MMP-2).Gelatinase activity of MMP-2 is as-
sociated with interstitial fibrosis and ventricular dilata-
tion. MMP-2 activity might be not contradictory to in-
creased interstitial fibrosis because MMP-2 has been
shown to degrade non triple-helical collagens like
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A
B
Fig.3 A Zymography of left ventricular homogen-
ates comparing WT with β1TG at 3 months (m), 5 m
and 12 m of age. Pro-MMP-2 (72 kD) expression con-
tinuously increased in β1TG mice with progressive in-
terstitial fibrosis. MMP-2 activity (66 kD) is demon-
strated in β1TG mice with ventricular dilatation and
severe fibrosis at 12 m of age. HT1080, a fibrosarcoma
cell-line, is used for MMP-2 latent/active positive con-
trol. n=5/group. B Quantitative real-time PCR of
MMP-2 mRNA. Threshold cycle (Ct) values are pre-
sented as a ratio of MMP-2 mRNA to GAPDH mRNA
(left). Representative amplification plot of MMP-2
mRNA (ABI Prism 7700 detection system) Rnnormal-
ized reporter signal (right)
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gelatins and fibronectin [29] which may promote cleav-
age of fibronectin from β1-integrins located at car-
diomyocyte-matrix adhesions. Indeed, β1-integrin
downstream signaling (integrin-linked kinase,ILK) was
significantly impaired in failing β1-adrenoceptor trans-
genic mice.
In β1TG pro-collagen type-I and -III mRNA and in-
terstitial collagen protein expression was progressively
increased from four fold at 5 months and finally to 17-
fold at 12 months compared to 3 months of age.In β1TG
at 5 months of age with compensated cardiac hypertro-
phy,we observed an increased deposition of type-I and
-III collagen fibers (polarization microscopy) surround-
ing the cardiomyocytes. Conversely, in the β1TG group
at 12 months of age asymmetrical distribution of the
collagen fibers with interruption of the collagen net-
work structure was shown in Sirius red stained sections
of the left ventricle. The turnover of collagens is regu-
lated by proteolytic matrix metalloproteinase (MMP)
activity and their endogenous tissue inhibitors (TIMPs).
Progressive interstitial fibrosis was accompanied by in-
creased expression levels of proMMP-2, MMP-2, TIMP-
2,the membrane bound MT1-MMP (MMP-14),and the
collagen type I degrading enzymes MMP-1 and MMP-
13. Increased MMP activity has been indicated in both
animal and human studies of heart failure with ventric-
ular dilatation and fibrosis [19,21,26,27].In particular,
these studies observed MMP/TIMP profiles which favor
extracellular matrix (ECM) degradation. Since in these
models increased myocardial fibrosis was observed,
these data and those reported herein provide evidence
for a dysbalance between formation and degradation of
interstitial fibrous tissue.
In β1TG mice with hypertrophy, increased left ven-
tricular protein expression of pro-MMP isoforms, such
as the collagenases (MMP-1, MMP-13), the gelatinase
proMMP-2 and the membrane bound MT1-MMP, pre-
ceded the development of ventricular dilatation. Com-
Fig.4 Immunoblot and densitometric quantification of tissue inhibitor of matrix
metalloproteinase-2 (TIMP-2; 24 kD). TIMP-2 expression continuously increased in
β1TG mice with progressive interstitial fibrosis and ventricular dysfunction. Corre-
sponding blot of the housekeeping protein calsequestrin is shown below;
n=5/group
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pensated hypertrophy was associated with increased
myocardial TIMP-1 and TIMP-2 levels,which would im-
ply reduced MMP collagenase activity.This is in agree-
ment with the concept that diminished myocardial
MMP collagenase activity can facilitate collagen accu-
mulation in developing hypertrophy [20, 21]. TIMP-1
protein expression also increased with age in the WT
group but protein enhancement was more pronounced
in β1TG mice. These data suggest a role for the control
of cardiac MMP-1 and -13 proteolytic activity by TIMP-
1. The fact that protein expression of the collagenases
MMP-1 and MMP-13 was accompanied by elevated
TIMP-1 levels is compatible with results in chronic pres-
sure-overload induced hypertrophy but contrasts to
models with acute pressure-overload showing an in-
crease in MMP activity [22].
β1TG mice developed dilatation and heart failure at
the age of 12 months [11]. Total collagenase (MMP-1,
MMP-13) protein expression decreased but membrane
bound MT1-MMP (MMP-14), TIMP-2 protein expres-
sion and MMP-2 gelatinase activity significantly in-
creased in β1TG mice at 5 and further at 12 months of
age.We observed a weak signal of zymographic MMP-2
activity in some ofthe β1TG mice at 5 months ofage pre-
ceding transition to ventricular dilatation.Gelatinolytic
MMP-2 activity, measured by gelatin zymography, in-
creased up to 3.6-fold in β1TG with decompensated
heart failure symptoms at the age of12 months.Our data
support the hypothesis that activation of the gelatinase
MMP-2 accompanies left ventricular remodeling and di-
latation.TIMP-2 is known as an inhibitor of MMP-2 ac-
tivity but also participates in proMMP-2 activation, in-
volving binding of proMMP-2 to a membrane-bound
MT1-MMP/TIMP-2 receptor complex [15, 33]. MT1-
MMP has been localized to the cell membrane and in
proximity to the ECM-binding integrins [24].α2β1 inte-
grin is the major collagen type I receptor and located in
focal adhesions in cardiomyocyte and fibroblast mem-
branes [9].Myocardial fibrillar collagens,such as colla-
gen types I and III, are essential for maintaining align-
ment of the myofibrils within the myocytes through a
collagen-integrin-cytoskeletal myofibril relation [6, 17,
24]. Integrin signaling is important in the maintenance
of normal myocardial structure and function [24].
MMP-2 activity may promote cleavage of fibronectin
from  β1-integrins located at cardiomyocyte-matrix
adhesions. Indeed, β1-integrin activity measured by
downstream signaling (integrin-linked kinase,ILK) was
significantly impaired in failing β1-adrenoceptor trans-
genic mice at the age of 12 months.Since ILK is involved
in cellular regulation of cell survival and proliferation
[10,32],disruption of cell-matrix adhesions could be in-
volved in cardiomyocyte slippage, replacement fibrosis
and finally ventricular dilatation.Sakata and coworkers
[25] observed enhanced total MMP protein expression
and activity in Dahl salt-sensitive rats (26 weeks) with
LV dilatation and systolic dysfunction compared to ear-
lier stages providing evidence that gelatinolytic activity
precedes LV dilatation. Iwanaga etal. [16] showed, in
Dahl salt-sensitive rats with compensated left ventricu-
lar hypertrophy (11 weeks),no changes in the hypertro-
phy stage, but increased MMP-2 mRNA, protein level
and activity as well as TIMP-2 protein and mRNA levels
after development of dilatation and dysfunction. In
agreement targeted deletion of the MMP-2 gene reduced
LV rupture and late remodeling in mice after myocardial
infarction [14].These findings supported the data of the
present study. Spinale etal. [28] as well as Woodiwiss
etal.[31] found that,irrespective of changes in myocar-
dial collagen concentrations, a decrease in collagen
cross-linking paralleled left ventricular dilatation in a
rat model with pressure-overload and heart failure and
in rats with left ventricular dilatation induced by a seven
month-lasting ß-adrenoceptor stimulation with isopro-
terenol.A potential role of β-adrenoceptor stimulation
beyond replacement fibrosis has been provided by
Coker etal. [8]. They stimulated myocytes with isopro-
terenol and demonstrated increased MMP-2 content
and activity as well as increased MT1-MMP expression.
A positive correlation between noradrenaline and
MMP-2 in patients with severe congestive heart failure
and in vitro in human cardiac fibroblasts has been re-
Fig.6 Immunoblot and densitometric quantification of integrin-linked kinase
(ILK) protein expression of β1TG and age matched WT. ILK is recognized at 
59 kD (ILK control) and significantly downregulated in mice with severe interstitial
fibrosis and ventricular dilatation at 12 months of age. Corresponding blot 
of the housekeeping protein calsequestrin is shown below
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cently shown by Banfi etal. [4]. These data support the
link between neurohormonal stimulation and collagen
turnover.In conclusion the presented data provide evi-
dence that gelatinase activity ofMMP-2 accompanies re-
placement fibrosis and ventricular dilatation. MMP-2
activity may promote cleavage of fibronectin from β1-
integrins located at cardiomyocyte-matrix adhesions in
failing β1TG. The knowledge of the selective induction
of MMPs within the myocardium might have particular
relevance in future therapeutic approaches to prevent
progression of chronic heart failure disease.
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